NCT01703728
Controlled Ovarian Stimulation by HP-hMG for IVF / ICSI Cycles: Study on Ovarian Hyper Stimulation Syndrome in a Cohort of Women From 18 to 36 Years Old. No drug interventions Not Available Not Available completed NCT01843569
In Vitro Maturation (IVM) of Human Oocytes No drug interventions treatment Not Available withdrawn NCT00617864
The Effect of Human Albumin Infusion on VEGF Levels in Women at Risk for Ovarian Hyperstimulation Syndrome diagnostic Not Available withdrawn NCT02620605
The Influence of Timing of Cabergoline Initiation on Prevention of OHSS prevention 3 unknown_status NCT01268761
GnRH Antagonist for Treatment of Early Ovarian Hyperstimulation Syndrome treatment 3 completed NCT00756028
Short Versus Long Protocol for IVF and IVF+ICSI No drug interventions treatment 4 completed NCT00329693
Study Assessing the Effect of 3-week Treatment With One of Three Oral Doses of Quinagolide prevention 2 completed NCT02846493
Efficacy and Safety of Dexamethasone Prevention for Patients of Ovarian Hyperstimulation Syndrome treatment 2 unknown_status NCT01569256
Ovarian Hyperstimulation Syndrome and Cabergoline basic_science Not Available completed NCT02200952
Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS Not Available Not Available completed NCT01535859
Study of Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in In Vito Fertilization Cycles and Derivation of OHSS Biomarkers prevention 3 completed NCT01477970
Double GnRH Antagonist Daily Dose in Hyperresponding IVF/ICSI Cycles May Prevent the OHSS No drug interventions Not Available Not Available completed NCT00665041
Tolerability of Quinagolide in a Dose-titration Regimen in Oocyte Donors at Risk of Developing Ovarian Hyperstimulation Syndrome treatment 2 completed NCT03996434
Coasting Versus Antagonist Protocol in Patients at High Risk of OHSS prevention 4 completed NCT05588635
Association Between Live Birth Rate and Serum Progesterone During Hormonal Replacement Therapy No drug interventions Not Available Not Available completed NCT00119925
'SPRING'-Study: "Subfertility Guidelines: Patient Related Implementation in the Netherlands Among Gynaecologists" No drug interventions Not Available Not Available unknown_status NCT01714648
Can GnRH Agonist Trigger Prevent Ovarian Hyperstimulation Syndrome? prevention 4 terminated NCT04351126
Management of Ovarian Hyperstimulation Syndrome as a State of Defective Mineralocorticoid Response treatment 2 completed NCT02392520
Luteal Antagonist Versus Conventional Treatment in Women With Severe Early Ovarian Hyperstimulation Syndrome (OHSS) treatment Not Available unknown_status NCT00365027
Transfer of Fresh Versus Frozen/Thawed Embryos in IVF Cycles Where GnRH Agonist is Utilized for Oocyte Maturation. No drug interventions treatment Not Available withdrawn NCT06333691
Comparative Study Between Calcium Gluconate With Diosmin, Cabergoline and Cabergoline With Diosmin prevention Not Available completed NCT05638529
Dual Trigger" in IVF Patients at High Risk of Ovarian Hyper Stimulation Syndrome treatment 4 active_not_recruiting NCT00417144
Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients prevention 4 unknown_status NCT01014104
Administration of Methylprednisolone for Prevention of Ovarian Hyper Stimulation Syndrome prevention 1 / 2 completed NCT03071172
Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET treatment 3 unknown_status NCT02686151
The Letrozole Administration During Luteal Phase prevention 3 not_yet_recruiting NCT03876145
The Four Methods of Ovarian Stimulation in Patients With Polycystic Ovarian Syndrome No drug interventions treatment Not Available completed NCT02329483
Monitoring the Early Follicular Phase With Androstenedione in Low-dose Step-up Ovulation Induction in High Responders No drug interventions Not Available Not Available unknown_status NCT05198128
Ovarian Hyperstimulation Syndrome Using Calcium Infusion treatment Not Available unknown_status NCT03188471
Preventive Application of GnRH Antagonist on Early OHSS prevention 4 unknown_status NCT02202278
Study of Serum Levels of Oxidative Stress Markers in Ovarian Hyperstimulation Patients No drug interventions Not Available Not Available unknown_status NCT01606709
Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation diagnostic 4 terminated NCT00480337
In Vitro Maturation of Immature Oocytes No drug interventions treatment Not Available completed NCT03794037
Montelukast for Prevention & Treatment of OHSS prevention 2 suspended NCT02701452
Ovarian Hyperstimulation Syndrome in Patients Triggered by GnRH Agonist for Excessive Follicular Response No drug interventions diagnostic Not Available terminated NCT00867659
The Role of Cetrotide Acetate in Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in Oocyte Donors prevention Not Available completed NCT01979341
The Effect of a Dual Trigger on Intracytoplasmic Sperm Injection (ICSI) Reproductive Outcomes No drug interventions treatment Not Available withdrawn NCT05362734
Freeze All Strategy Versus Fresh Embryo Transfer After GnRH Analogue Trigger No drug interventions Not Available Not Available completed NCT00440258
Cabergoline Reduces OHSS prevention 3 completed NCT00349258
The Use of GnRH Agonist Trigger in the Prevention of OHSS prevention 4 completed NCT01427335
Calcium for Prevention of Ovarian Hyperstimulation Syndrome prevention 3 completed NCT01500863
Endometrial Receptivity After GnRH Agonist Triggering treatment 4 completed NCT02084940
Long Acting GnRH Antagonist in PCOS Women Undergoing IVF Not Available Not Available unknown_status NCT01009567
Compare the Efficacy of Human Albumin With Cabergoline to Prevent Ovarian Hyper Stimulation in Assisted Reproductive Technology (ART) Program prevention 1 / 2 completed NCT02670304
Preventive Application of Letrozole Decrease Incidence of Early Onset of OHSS prevention 4 completed NCT00835523
Ovarian Hyperstimulation Syndrome (OHSS) Prevention With Agonist No drug interventions Not Available Not Available completed NCT02610608
Medical Assistance for the Procreation and Risk of Thrombosis. No drug interventions Not Available Not Available terminated NCT01815138
Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS treatment 4 completed NCT04797338
Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders treatment 4 unknown_status